Sg Americas Securities, LLC Inhibrx, Inc. Transaction History

Sg Americas Securities, LLC

  • $20.8 Billion
  • Q1 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023
BUY
$18.45 - $27.14 $199,702 - $293,763
10,824 Added 249.46%
15,163 $286,000
Q4 2022

Feb 02, 2023
SELL
$20.18 - $33.33 $36,727 - $60,660
-1,820 Reduced 29.55%
4,339 $107,000
Q3 2022

Oct 31, 2022
BUY
$11.58 - $24.73 $71,321 - $152,312
6,159 New
6,159 $111,000
Q1 2022

Apr 29, 2022
SELL
$19.89 - $43.18 $118,842 - $258,000
-5,975 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$26.75 - $46.02 $125,618 - $216,109
-4,696 Reduced 44.01%
5,975 $261,000
Q3 2021

Nov 01, 2021
BUY
$25.18 - $37.81 $268,695 - $403,470
10,671 New
10,671 $355,000

Others Institutions Holding INBX

# of Institutions
132
Shares Held
35.5M
Call Options Held
64.8K
Put Options Held
91.3K
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $553M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email